Q3 2023 · 13F-HR
Alerce Investment Management, L.P.holdings as filed
Filed 2023-11-13 · accession 0000895345-23-000616
$58.5M
Reported value
6
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $18.5M | 31.6% | 16,205,119 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $16.7M | 28.5% | 7,056,024 | Common | SOLE |
| 03044L105 | — | AMERICAN WELL CORP | $12.3M | 20.9% | 10,475,717 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $7.9M | 13.5% | 1,630,830 | Common | SOLE |
| 045396108 | — | ASSEMBLY BIOSCIENCES INC | $2.0M | 3.37% | 2,227,500 | Common | SOLE |
| 00887A204 | RNTX | AILERON THERAPEUTICS INC | $1.3M | 2.16% | 830,466 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.